Home>Publications>Economic model for ResVax for maternal vaccination against infant respiratory syncytial virus disease in the United States
Herring W, Rosen B. Economic model for ResVax for maternal vaccination against infant respiratory syncytial virus disease in the United States. Presented at the 2019 Respiratory Syncytial Virus Consortium in Europe; June 2019. Utrecht, The Netherlands.
Abstract not available at this time.
RTI Health Solutions®
The power of knowledge. The value of understanding.
Steeped in a tradition of rigor and process, we maintain a legacy of setting the scientific standards within our industry. We employ the right approaches and proven research practices to analyze evidence and draw meaningful insights. Our uncompromisingly ethical and objective researchers ensure that results will hold up to scrutiny and reveal the benefits, risks, value and potential of your products. Learn more.